A randomized trial of subcutaneous allergy immunotherapy in inner-city asthmatic children < 4 years of age.
CONCLUSION: With the exception of asthma related quality of life, allergy immunotherapy was ineffective in improving asthma outcomes in this population of inner-city children < 4 years of age. These findings suggest that the effects of allergy immunotherapy depend on population specific factors and highlight the importance of precise predictors of immunotherapy efficacy.
PMID: 33418053 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: de Vos G, Viswanathan S, Pichardo Y, Nazari R, Jorge Y, Ren Z, Serebrisky D, Rosenstreich D, Wiznia A Tags: Ann Allergy Asthma Immunol Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | Environmental Health | Immunotherapy | Study